EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Classic Psychedelics for Treating Chronic Pain: Mechanism and Clinical Translation

Hongyu Chen, Bowen Ke, Ruotian Jiang iD

Molecules · 27.07.2026 · 31 (15) · 2611

DOI: 10.3390/molecules31152611 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 27.07.2026. Verfasst von Hongyu Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu 610000, China. Hauptthemen laut MEDLINE: Chronic Pain, Hallucinogens. Die Arbeit nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain Science and Brain-like Intelligence Technology-National Science and Technology Major Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pain is a complex disorder of central nervous system maladaptation, perpetuated not only by ascending nociceptive transmission but also by entrenched prior expectations. Conventional analgesics typically fail to reverse this cognitive rigidity and the ensuing pathological cycles. Classic psychedelics, however, are emerging as a promising avenue to help address this therapeutic impasse. This narrative review provides a comprehensive overview of the emerging science of psychedelics, encompassing their biological binding targets, potential neural mechanisms and clinical applications, in the context of chronic pain. We synthesize the therapeutic potential of classic psychedelics and critically examine the discrepancies between clinical outcomes and foundational mechanistic research. Furthermore, we evaluate key translational barriers, particularly compromised blinding and expectancy bias, and highlight the necessity for developing novel validation strategies. Ultimately, these new insights compel a fundamental rethinking of how biological neuroplasticity and subjective psychological experiences independently or synergistically drive analgesia, thereby offering a paradigm-shifting perspective for the translation of psychedelics into evidence-based analgesic therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic PainHallucinogensHumansNeuronal PlasticityAnimalsAnalgesicsTranslational Research, Biomedical

Stichwörter der Autor:innen

5-HT receptoranalgesiachronic painclassic psychedelicsdefault mode networkneuroplasticity

Substanzen

HallucinogensAnalgesics

Autor:innen und Institutionen

  • Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu 610000, China.
  • Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu 610000, China.

ORCID-Profile: Ruotian Jiang

Förderung

  • Brain Science and Brain-like Intelligence Technology-National Science and Technology Major Project
  • National Natural Science Foundation of China

Zitieren

APA

Chen, H., Ke, B., & Jiang, R. (2026). Classic Psychedelics for Treating Chronic Pain: Mechanism and Clinical Translation. Molecules, 31(15), 2611. https://doi.org/10.3390/molecules31152611

Vancouver

Chen H, Ke B, Jiang R. Classic Psychedelics for Treating Chronic Pain: Mechanism and Clinical Translation. Molecules. 2026;31(15):2611. doi:10.3390/molecules31152611

BibTeX
@article{Chen2026,
  author = {Chen, Hongyu and Ke, Bowen and Jiang, Ruotian},
  title = {Classic Psychedelics for Treating Chronic Pain: Mechanism and Clinical Translation},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {15},
  pages = {2611},
  doi = {10.3390/molecules31152611}
}
Kostenlos starten →